CTSH
57
-5
ORLY
62
-2
MSFT
57
2
IBM
79
-3
AZO
45
-3
AVB
67
-3
TJX
48
-6
MMC
62
-5
SLB
50
4
PPL
67
-2
NTRS
49
2
EW
16
-9
F
47
3
AMG
41
3
EFX
69
-6
MAR
47
2
OXY
42
6
KR
48
-4
SO
66
-2
CHK
27
7
CTSH
57
-5
ORLY
62
-2
MSFT
57
2
IBM
79
-3
AZO
45
-3
AVB
67
-3
TJX
48
-6
MMC
62
-5
SLB
50
4
PPL
67
-2
NTRS
49
2
EW
16
-9
F
47
3
AMG
41
3
EFX
69
-6
MAR
47
2
OXY
42
6
KR
48
-4
SO
66
-2
CHK
27
7
Financhill
Back

Bio-Rad Laboratories 10K Form

Sell
50

BIO
Bio-Rad Laboratories

Last Price:
340.66
Seasonality Move:
1.94%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive BIO News And Ratings

See the #1 stock for the next 7 days that we like better than BIO

BIO Financial Statistics

Sales & Book Value

Annual Sales: $2.67B
Cash Flow: $55.37M
Price / Cash Flow: 54.04
Annual Sales: $240.39
Price / Book: 1.37

Profitability

EPS (TTM): -47.03000
Net Income (TTM): $-1.33B
Gross Margin: $1.43B
Return on Equity: -16%
Return on Assets: -11.34%

Bio-Rad Laboratories Earnings Forecast

Key Bio-Rad Laboratories Financial Ratios

  • The Gross Profit Margin over the past 40 years for BIO is 53.42%.
  • The Selling, General & Administrative Expenses for BIO have been equal to 31.51% of Gross Profit Margin.
  • The Research & Development expenses have been 9.26% of Revenue.
  • The Interest Expense is -7.76% of Operating Income.
  • The Net Earning history of BIO is -23.86% of Total Revenues.
  • Per Share Earnings over the last 40 years have been positive in 27 years.

Bio-Rad Laboratories Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Life Sciences Tools & Services
Sector: Health Care
Current Symbol: BIO
CUSIP: 090572
Website: bio-rad.com

Debt

Debt-to-Equity Ratio: 0.18
Current Ratio: 6.28
Quick Ratio: 4.23

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 30.27

BIO Technical Analysis vs Fundamental Analysis

Sell
50
Bio-Rad Laboratories (BIO) is a Sell

Is Bio-Rad Laboratories a Buy or a Sell?